HISTOGENICS CORP - COM (HSGX)

CUSIP: 43358V109

Q3 2018 13F Holders as of 30 Sep 2018

Type / Class
Equity / COM
Total 13F shares
10,385,204
Share change
-3,005,062
Total reported value
$5,648,000
Price per share
$0.54
Number of holders
24
Value change
-$8,064,430
Number of buys
11
Number of sells
16

Quarterly Holders Quick Answers

What is CUSIP 43358V109?
CUSIP 43358V109 identifies HSGX - HISTOGENICS CORP - COM in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of HISTOGENICS CORP - COM (HSGX) as of Q3 2018

As of 30 Sep 2018, HISTOGENICS CORP - COM (HSGX) was held by 24 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 10,385,204 shares. The largest 10 holders included Third Security, LLC, Sofinnova Ventures Inc, PERCEPTIVE ADVISORS LLC, Vanguard Group Inc, Abingworth LLP, Archon Capital Management LLC, RENAISSANCE TECHNOLOGIES LLC, Palo Alto Investors LP, DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C), and Virtu Financial LLC. This page lists 24 institutional shareholders reporting positions in this security for the Q3 2018 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.